Showing 481 - 500 results of 804 for search '"Inflammatory bowel disease"', query time: 0.11s Refine Results
  1. 481

    New-Onset Ulcerative Colitis in a Young Caucasian Woman with Unclassified Arteritis by Bryan Roberts

    Published 2022-01-01
    “…Cases have been reported in patients with inflammatory bowel disease, suggesting possible genetic linkage. …”
    Get full text
    Article
  2. 482

    A Practical Review of Cytomegalovirus in Gastroenterology and Hepatology by Ali Y. Fakhreddine, Catherine T. Frenette, Gauree G. Konijeti

    Published 2019-01-01
    “…This review will focus on the pathophysiology, diagnosis, and management of CMV in patient populations relevant to the practice of gastroenterology and hepatology—liver transplant recipients, inflammatory bowel disease patients, and otherwise immunocompetent patients.…”
    Get full text
    Article
  3. 483

    Mechanism of action of 5-arninosalicylic acid by N. A. Punchard, S. M. Greenfield, R. P. H. Thompson

    Published 1992-01-01
    “…5-Aminosalicylic Acid (5-ASA) has been used for over 50 years in the treatment of inflammatory bowel disease in the pro-drug form sulphasalazine (SASP). …”
    Get full text
    Article
  4. 484

    Reactive Lymphoid Hyperplasia of the Liver Incidentally Found in a 55-Year-Old Woman with a History of Ulcerative Colitis by Noritoshi Mizuta, Takuya Kikuchi, Shunsuke Kusano, Nobuya Sano

    Published 2024-01-01
    “…No case was reported in association with inflammatory bowel disease. We report a case of RLH of the liver in a patient with ulcerative colitis (UC). …”
    Get full text
    Article
  5. 485

    Giant Cell Myocarditis in a Patient With Crohn's Disease, Treated with Etanercept – A Tumour Necrosis Factor-Alpha Antagonist by C Nash, R Panaccione, LR Sutherland, JB Meddings

    Published 2001-01-01
    “…Cardiac disease in association with inflammatory bowel disease (IBD) is uncommon. Reports include pericarditis, pericardial effusion, myocarditis, myocardial infarction, endocarditis and arrythmias. …”
    Get full text
    Article
  6. 486

    Multifocal Multisystem Langerhans Cell Histiocytosis Involving Pituitary Masquerading as Crohn’s Disease: A Case Report and Review of the Literature by Mohd. Ashraf Ganie, Bhanu Malhotra, Manpreet Saini, Arshiya Dutta, Atul Sharma, Kim Vaiphie, Pinaki Dutta

    Published 2022-01-01
    “…We present a case of Langerhans cell histiocytosis (LCH) with gastrointestinal involvement masquerading as inflammatory bowel disease (IBD) in a patient who initially had features of central diabetes insipidus (CDI). …”
    Get full text
    Article
  7. 487

    Highlights in IBD Epidemiology and Its Natural History in the Paediatric Age by Marco Gasparetto, Graziella Guariso

    Published 2013-01-01
    “…The number of patients of all age brackets diagnosed with Inflammatory Bowel Disease (IBD) has risen dramatically worldwide over the past 50 years. …”
    Get full text
    Article
  8. 488
  9. 489

    Caveolin-1 Scaffolding Domain Peptide Regulates Colon Endothelial Cell Survival through JNK Pathway by Kai Fang, Christopher G. Kevil

    Published 2020-01-01
    “…It has been reported that pathological angiogenesis contributes to both experimental colitis and inflammatory bowel disease. Recently, we demonstrated that endothelial caveolin-1 plays a key role in the pathological angiogenesis of dextran sodium sulfate (DSS) colitis. …”
    Get full text
    Article
  10. 490

    Lymphocyte levels in Crohn’s disease patients in clinical remission are significantly lower than those in healthy people by Asi He, Tulan Hu, Linzhen Li

    Published 2025-02-01
    “…Abstract Background and purpose Inflammatory bowel disease (IBD) is a chronic, non-specific inflammatory bowel disease caused by multiple causes. …”
    Get full text
    Article
  11. 491

    Renal Effects of Long-Term Treatment with 5-Aminosalicylic Acid by Harshna Patel, Aiala Barr, Khursheed N Jeejeebhoy

    Published 2009-01-01
    “…BACKGROUND: A number of case reports link the use of 5-aminosalicylic acid (5-ASA) to interstitial nephritis in patients with inflammatory bowel disease (IBD).…”
    Get full text
    Article
  12. 492

    Unique quantitative electroencephalography differences and related behavioral dynamics in Crohn’s disease by Yihan Zhuang, Hairu Yang, Xinyi Huang, Guanghua Guo, Quan Shi, Yiting Lin, Wenwen Xue, Zeyu Huang, Sisi Zhou, Jiahui Cai, Haizhu Tan, Jing Yu

    Published 2024-12-01
    “…Crohn's disease (CD) is a major type of inflammatory bowel disease (IBD) characterized by idiopathic, chronic inflammation with a patchy transmural inflammatory pattern. …”
    Get full text
    Article
  13. 493

    The Impact of Intermediate Antidrug Antibodies to Infliximab and Adalimumab on Clinical Outcomes in Patients with Crohn’s Disease or Ulcerative Colitis by Chaoyang Wang, Mazen Tolaymat, Raymond Cross

    Published 2022-03-01
    “… Background: The anti-TNF drugs adalimumab (ADA) and infliximab (IFX) are effective treatments for inflammatory bowel disease (IBD). However, 40% of patients lose response, often due to the development of antibodies-to-ADA (ATA) and antibodies-to-IFX (ATI). …”
    Get full text
    Article
  14. 494

    Prevalence of Erosive-ulcerative Lesions of the Stomach and Helicobacter Pylori Infection in Patients with Ulcerative Colitis by N. A. Ponkratova, P. V. Pavlov, O. S. Shifrin

    Published 2019-06-01
    “…The study of H. pylori infection with RUT was carried out in 111 patients without inflammatory bowel disease, who formed the control group.Results. …”
    Get full text
    Article
  15. 495

    Ketotifen Treatment of Active Colitis in Patients with 5-Aminosalicylate Intolerance by John K Marshall, E Jan Irvine

    Published 1998-01-01
    “…Although the role of mucosal mast cells in the pathogenesis of inflammatory bowel disease remains uncertain, mast cell stabilizers have been shown in animal models to attenuate the severity of experimental colitis. …”
    Get full text
    Article
  16. 496
  17. 497

    Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn’s Disease: Apropos of a Case by Michele Sorleto, Stefanie Dürrwald, Marcus Wiemer

    Published 2015-01-01
    “…Mesalazine- (5-aminosalicylic acid-) containing products are a well-known treatment for inflammatory bowel disease, often as first line. Myocarditis is recognized as a very rare possible side effect of this drug treatment. …”
    Get full text
    Article
  18. 498

    2009 Canadian Association of Gastroenterology Educational Needs Assessment Report by Alaa Rostom, Sandra Daniels

    Published 2009-01-01
    “…Similar to previous years, inflammatory bowel disease (IBD) topics – particularly Crohn’s disease and ulcerative colitis (UC) therapeutics, and difficult IBD cases – were most in demand for future educational events. …”
    Get full text
    Article
  19. 499

    Ilececum: A Comprehensive Review by Shou-jiang Tang, Ruonan Wu

    Published 2019-01-01
    “…Ileal intubation is indicated in certain circumstances such as suspected inflammatory bowel disease and GI bleeding. There is much pathology that can be observed within the ileocecum. …”
    Get full text
    Article
  20. 500

    A Gastroenterologist’s Perspective of The Medical Management of Patients with Crohn’s Disease and Ulcerative Colitis by ABR Thomson

    Published 1996-01-01
    “…Medical therapy in patients with inflammatory bowel disease (IBD) has specific objectives that need to be remembered when considering any form of intervention. …”
    Get full text
    Article